Proof of efficacy of Kamillosan(R) cream in atopic eczema.

R Patzelt-Wenczler, E Ponce-Pöschl

Journal: European journal of medical research 2000;5(4):171-5

PMID: 10799352

Abstract

Kamillosan(R) cream contains chamomile extract as active principle manufactured from the chamomile sort Manzana which is rich in active principles and has been proved not to exhibit a chamomile-related allergen potential. For this reason Kamillosan(R) cream is suited for local therapy of atopic eczema. In a partially double-blind, randomized study carried out as a half-side comparison, Kamillosan(R) cream was tested vs. 0.5% hydrocortisone cream and the vehicle cream as placebo in patients suffering from medium-degree atopic eczema. After a 2-week treatment Kamillosan(R) cream showed a mild superiority towards 0.5% hydrocortisone and a marginal difference as compared to placebo.

Address: ASTA Medica AG, Weismüllerstr. 45, D-60314 Frankfurt am Main, Germany. [email protected]

MeSH Terms: Administration, Topical, Anti-Inflammatory Agents, Arachidonic Acid, Arm, Chamomile, Dermatitis, Atopic, Drug Combinations, Erythema, Humans, Hydrocortisone, Middle Aged, Oils, Volatile, Phytotherapy, Plant Extracts, Plants, Medicinal, Pruritus, Sesquiterpenes, Treatment Outcome